|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12P 21/02 | (2006.01) |
| C07K 14/50 | (2013.01) | ||
| C07K 14/50 | (2006.01) | ||
| G01N 33/92 | (2013.01) | ||
| A61K 38/18 | (2006.01) | ||
| G01N2500/04 | (2013.01) | ||
| A61P 1/12 | (2006.01) | ||
| G01N2800/04 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| G01N2800/08 | (2013.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61K 38/1825 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 1/12 | (2018.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Patento numeris | 2938740 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13868063.2 |
| Europos patento paraiškos padavimo data | 2013-12-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/077782 |
| Data | 2013-12-26 |
| (87) | Numeris | WO 2014/105939 |
| Data | 2014-07-03 |
| (30) | Numeris | Data | Šalis |
| 201261746499 P | 2012-12-27 | US | |
| 201361779604 P | 2013-03-13 | US | |
| 201361887129 P | 2013-10-04 | US |
| (72) |
LING, Lei , US
LUO, Jian , US
|
| (73) |
NGM Biopharmaceuticals, Inc. ,
333 Oyster Point Blvd., South San Francisco CA 94080,
US
|
| (54) | CHIMERIC FGF19 PEPTIDES FOR USE IN TREATING BILE ACID DISORDERS |
| CHIMERIC FGF19 PEPTIDES FOR USE IN TREATING BILE ACID DISORDERS |